Literature DB >> 9287375

Abnormalities in skeletal growth in children with juvenile rheumatoid arthritis.

J T Cassidy1, L S Hillman.   

Abstract

A review of the acquisition of peak skeletal mass in normal children and studies that have been reported for children with JRA lead to the following tentative conclusions: (1) The appendicular skeleton is predominantly the overall status of skeletal mineralization; (2) a failure to develop adequate bone mineralization is virtually universal in children with JRA and is characterized by a failure of bone formation. A failure to undergo the normal increase in bone mass during puberty is common in children with JRA and markedly decreases their potential to achieve an adequate peak skeletal mass; (3) the onset of accelerated skeletal maturation with puberty is a critical period of potential intervention in JRA. Conversely, therapeutic interventions later during adolescence offer less promise of reversal of inadequate bone mineralization; and (4) the most important therapeutic maneuver is likely to be control of the inflammation process, although there is hope, at present unsubstantiated, that supplemental dietary calcium and vitamin D, and normalization of physical activity, many lead to some "catch-up" mineralization.

Entities:  

Mesh:

Year:  1997        PMID: 9287375     DOI: 10.1016/s0889-857x(05)70345-8

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  10 in total

1.  The impact of corticosteroids on growth and bone health.

Authors:  T Mushtaq; S F Ahmed
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

Review 2.  Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.

Authors:  Yujuan Zhang; Diana Milojevic
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

Review 3.  Mechanisms of growth impairment in pediatric Crohn's disease.

Authors:  Thomas D Walters; Anne M Griffiths
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09       Impact factor: 46.802

Review 4.  Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment.

Authors:  Emily von Scheven; Kathleen Jo Corbin; Stefano Stagi; Stagi Stefano; Rolando Cimaz
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

5.  Growth and bone mineralization in patients with juvenile idiopathic arthritis.

Authors:  Ozgur Okumus; Muferet Erguven; Murat Deveci; Oznur Yilmaz; Mine Okumus
Journal:  Indian J Pediatr       Date:  2008-03       Impact factor: 1.967

6.  An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6.

Authors:  A Del Fattore; A Cappariello; M Capulli; N Rucci; M Muraca; F De Benedetti; A Teti
Journal:  Osteoporos Int       Date:  2013-08-14       Impact factor: 4.507

7.  Drosophila growth and development: keeping things in proportion.

Authors:  Ditte S Andersen; Julien Colombani; Pierre Léopold
Journal:  Cell Cycle       Date:  2012-08-08       Impact factor: 4.534

8.  Automated determination of bone age and bone mineral density in patients with juvenile idiopathic arthritis: a feasibility study.

Authors:  Janneke Anink; Charlotte M Nusman; Lisette W A van Suijlekom-Smit; Rick R van Rijn; Mario Maas; Marion A J van Rossum
Journal:  Arthritis Res Ther       Date:  2014-08-27       Impact factor: 5.156

9.  Bone mineral density in children wth systemic lupus erythematosus and juvenile rheumatoid arthritis.

Authors:  Sara Kashef; Forugh Saki; Zohreh Karamizadeh; Mohammad Amin Kashef
Journal:  Ann Saudi Med       Date:  2007 Nov-Dec       Impact factor: 1.526

10.  Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children.

Authors:  Rocío Galindo-Zavala; Rosa Bou-Torrent; Berta Magallares-López; Concepción Mir-Perelló; Natalia Palmou-Fontana; Belén Sevilla-Pérez; Marta Medrano-San Ildefonso; Mª Isabel González-Fernández; Almudena Román-Pascual; Paula Alcañiz-Rodríguez; Juan Carlos Nieto-Gonzalez; Mireia López-Corbeto; Jenaro Graña-Gil
Journal:  Pediatr Rheumatol Online J       Date:  2020-02-24       Impact factor: 3.054

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.